• Guardant Health Inc GH.OQ reported a quarterly adjusted loss of 90 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -64 cents. The mean expectation of twenty three analysts for the quarter was for a loss of 74 cents per share. Wall Street expected results to range from $-1.02 to -45 cents per share.

• Revenue rose 30.2% to $201.81 million from a year ago; analysts expected $192.14 million.

• Guardant Health Inc's reported EPS for the quarter was a loss of 90 cents​.

• The company reported a quarterly loss of $111.01 million.

• Guardant Health Inc shares had risen by 55.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 6.4% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Guardant Health Inc is $47.00

This summary was machine generated from LSEG data February 21 at 05:06 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)